Performance for the quarter ended June 2016

The top-line was flat at Rs 558.27 crore due to overall category slowdown on Health Care.

OPM has inclined by 70 bps to 28.4% due to decrease in purchase of stock in trade by 540 bps to 9.8% and ASP cost by 140 bps to 11.5% of adjusted net sales. The operating profit increased by 3% to Rs 158.57 crore.

Other income increased by 18% to Rs 22.18 crore. Interest cost increased by 10% to Rs 0.33 crore. Depreciation has decreased by 7% to Rs 12.41 crore. PBT has increased by 5% to Rs 168.01 crore.

The tax outgo inclined by 12% to Rs 58.61 crore. The effective tax rate inclined from 32.9% to 34.9%. The net profit has increased by 2% to Rs 109.40 crore.

Performance for fiscal year ended June 2016

The top-line inclined by 6% to Rs 2484.33 crore. The Feminine care business continued to deliver strong double digit sales growth in a competitive market environment behind superior value propositions and strength of product portfolio. Due to category slowdown, sales in the Health Care Business remained flat.

OPM has inclined by 360 bps to 24.3% due to fall in raw material cost, purchase of stock in trade and ASP. The operating profit increased by 25% to Rs 604.64 crore.

Other income increased by 17% to Rs 87.61 crore. Interest cost decreased by 30% to Rs 4.02 crore. Depreciation declined by 2% to Rs 51.69 crore. PBT has increased by 27% to Rs 636.54 crore.

The tax outgo inclined by 38% to Rs 213.36 crore. The effective tax rate increased from 30.9% to 33.5%. The net profit has increased by 22% to Rs 423.18 crore due to increase in margin.

The board of directors has recommended for current year a final dividend of Rs 36 per equity share

The promoters hold 70.64% stake in the company

The shares of the company are trading around Rs 6585 at BSE.